What does this research mean for the field?

Transplantation of BMSCs-IL-10+ cells reduces neuropathic pain in CCD rats by enhancing IL-10 expression and suppressing IRF-8. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Investigate the role of the IL-10-IRF-8 signaling pathway in BMSC therapy for pain relief in CCD rats.

March 1, 2026Open Access

EXPRESS: Study on the Role and Mechanism of the IL-10-IRF-8 Signaling Pathway in Bone Marrow Mesenchymal Stem Cell Therapy for Pain in CCD Rats

Key Points

Investigate the role of the IL-10-IRF-8 signaling pathway in BMSC therapy for pain relief in CCD rats.
Examined the effects of BMSCs-IL-10+ cell transplantation in CCD rats
Measured levels of IL-10 and IRF-8
Assessed glial activation and neuroinflammation levels
BMSCs-IL-10+ cells significantly reduced glial activation
Transplantation alleviated neuroinflammation
Enhanced IL-10 expression correlated with reduced neuropathic pain levels

Abstract

IL-10 is a key cytokine mediating the analgesic effects of BMSCs. Transplantation of BMSCs-IL-10+ cells reduces glial activation, alleviates neuroinflammation, and relieves neuropathic pain by enhancing IL-10 expression and suppressing IRF-8.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Yang et al. (Fri,) studied this question.

synapsesocial.com/papers/69a3d873ec16d51705d2f47c https://doi.org/https://doi.org/10.1177/17448069261432034

Bookmark

View Full Paper